Chesapeake Energy Corporation (NYSE:CHK)
On Monday, Chesapeake Energy Corporation (NYSE:CHK)’s shares inclined 3.93% to $6.34.
CHK is currently valued at $4.06 billion. The company has 665.07 million shares outstanding and 96.10% shares of the company were owned by institutional investors. The company has 0.31 value in price to sale ratio while price to book ratio was recorded as 3.45. The company exchanged hands with 18.47 million shares as compared to its average daily volume of 19.38 million shares. It beta stands at 1.39.
The mean estimate for the short term price target for Chesapeake Energy Corporation (NYSE:CHK) stands at $8.57 according to 27 Analysts. The higher price target estimate for the stock has been calculated at $13.00 while the lower price target estimate is at $5.00.
Analysts mean recommendation for the stock is -3.20. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Chesapeake Energy Corporation is a producer of natural gas, oil and natural gas liquids (NGL) in the United States. The Company operates in two segments: Exploration and Production, and Marketing, Gathering and Compression.
Great Basin Scientific Inc (NASDAQ:GBSN)
Great Basin Scientific Inc (NASDAQ:GBSN)’s shares gained 4.60% to $0.0659.
The company has the market capitalization of $12.01 million. Return on assets ratio of the company was -423.80% while its return on equity ratio was 140.50%. ATR value of company was 0.01 while stock volatility for week was 9.18% while for month was 14.33%.
The mean estimate for the short term price target for Great Basin Scientific Inc (NASDAQ:GBSN) stands at $9.69 according to 2 Analysts. The higher price target estimate for the stock has been calculated at $10.00 while the lower price target estimate is at $9.38.
Analysts mean recommendation for the stock is 2.00. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Great Basin Scientific, Inc. is a molecular diagnostic testing company. The Company is focused on the development and commercialization of its molecular diagnostic platform designed to test for infectious disease.
People’s United Financial, Inc. (NASDAQ:PBCT)
At the end of Monday’s trade, People’s United Financial, Inc. (NASDAQ:PBCT)‘s shares surged 1.53% to $16.54.
PBCT offered 22.90% EPS for prior five years. The company has 5.40% return on equity value while its ROI ratio was 13.10%. The company has $5.05 billion market capitalizations and the institutional ownership was 84.50%. Its price to book ratio was 1.05. Volatility of the stock was 1.82% for the week while for the month booked as 1.93%.
The mean estimate for the short term price target for People’s United Financial, Inc. (NASDAQ:PBCT) stands at $15.11 according to 14 Analysts. The higher price target estimate for the stock has been calculated at $17.00 while the lower price target estimate is at $13.00.
Analysts mean recommendation for the stock is -3.20. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
People’s United Financial, Inc. is a savings and loan holding company. It is a holding company for People’s United Bank (the Bank), a federally-chartered stock savings bank headquartered in Bridgeport, Connecticut.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.